icotec, a leading company for the treatment of spinal tumours and spinal infections, announced that it has received FDA clearance for the use of BlackArmor implants in the treatment of de novo spinal ...
In addition to the on-label designation, the FDA has also granted a Breakthrough Device Designation (BDD) for this indication across the entirety of icotec's BlackArmor® spinal stabilization ...
The US Food and Drug Administration (FDA) has granted clearance to icotec for the use of its BlackArmor implants in treating de novo spinal infections. This is claimed to make icotec the first and ...
EAST HARTFORD, Conn., Jan. 14, 2025 /PRNewswire/ -- icotec is proud to announce that it has received FDA clearance for the use of BlackArmor® implants in the treatment of de novo spinal infections.
EAST HARTFORD, Conn., Jan. 14, 2025 /PRNewswire/ -- icotec is proud to announce that it has received FDA clearance for the use of BlackArmor® implants in the treatment of de novo spinal infections.
3. Spine devicemaker icotec earned FDA 510(k) clearance for its BlackArmor spine implants. 4. Ventris Medical earned FDA 510(k) clearance for its Backpack bone graft containment system. 5. Onward's ...
EAST HARTFORD, Conn., Jan. 14, 2025 /PRNewswire/ -- icotec is proud to announce that it has received FDA clearance for the use of BlackArmor® implants in the treatment of de novo spinal infections.
3. Spine devicemaker icotec earned FDA 510(k) clearance for its BlackArmor spine implants. 4. Private equity firm Montagu has entered into a definitive agreement to acquire orthopedic device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback